Research guide for for bodybuilding — mechanisms, protocols, and independent analysis from Compound Review.
Why IGF-1 LR3 Works for Bodybuilding
IGF-1 LR3 activates the IGF-1 receptor (IGF-1R) with greater potency and duration than endogenous IGF-1 due to reduced IGFBP binding. In skeletal muscle, this drives satellite cell proliferation and differentiation — the mechanism underlying muscle hyperplasia (new fiber formation) rather than just hypertrophy (fiber enlargement). This theoretical distinction from other anabolic compounds drives interest among bodybuilders seeking long-term structural muscle gains.
IGF-1 LR3 Bodybuilding Dosage Protocol
Bodybuilding protocols typically use 50–100 mcg post-workout injected intramuscularly into the trained muscle group. Cycles are limited to 4 weeks to prevent receptor downregulation and to limit cumulative IGF-1 exposure. Some protocols use bilateral injections targeting lagging muscle groups. IGF-1 LR3 is often used during bulking phases alongside GH secretagogues or exogenous GH.
IGF-1 LR3 vs CJC-1295 vs Ipamorelin for Bodybuilding
No human RCTs have evaluated IGF-1 LR3 for body composition in healthy subjects. The mechanistic rationale for muscle hyperplasia is supported by in vitro and animal data. Practical bodybuilding outcomes are reported anecdotally. Key risks include hypoglycemia (IGF-1 has insulin-like activity), acromegalic side effects at high doses, and theoretical promotion of pre-existing malignancies.